Is ARS Pharmaceuticals, Inc. (SPRY) a Buy, Sell, or Hold?
ARS Pharmaceuticals, Inc.
NASDAQ:SPRY
$7.61 USD
-$0.13 (-1.68%)
- Volume
- 1.91M
- Average Volume
- 1.8M
- Market Capitalization
- $755.7M
- P/E Ratio
- -3.79
- Dividend Yield
- 0.00%
- Price Target
- $25.50
- Year High
- $18.63
- Year Low
- $6.66
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.94
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
22
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
10
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 643.39K
SPRY Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
SPRY Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Casale Donn | officer: President | 2026-07-01 | A-Award | 7.96 | 2026-07-02 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2026-06-24 | A-Award | 10.54 | 2026-06-26 |
| Dadoo Rajeev | director | 2026-06-24 | A-Award | 10.54 | 2026-06-26 |
| Shah Pratik | director | 2026-06-24 | A-Award | 10.54 | 2026-06-26 |
| Kelly Michael | director | 2026-06-24 | A-Award | 10.54 | 2026-06-26 |
| Islam Saqib | director | 2026-06-24 | A-Award | 10.54 | 2026-06-26 |
| Thompson Peter A. | director | 2026-06-24 | A-Award | 10.54 | 2026-06-26 |
| SAUNDERS BRENT L | director | 2026-06-24 | A-Award | 10.54 | 2026-06-26 |
| SCHNEIDER PHILLIP M | director | 2026-06-24 | A-Award | 10.54 | 2026-06-26 |
| Shawver Laura | director | 2026-06-24 | A-Award | 10.54 | 2026-06-26 |
| Karas Eric | officer: Chief Commercial Officer | 2026-06-12 | M-Exempt | 1.5 | 2026-06-12 |
| Karas Eric | officer: Chief Commercial Officer | 2026-06-12 | M-Exempt | 1.5 | 2026-06-12 |
| Karas Eric | officer: Chief Commercial Officer | 2026-06-12 | S-Sale | 10 | 2026-06-12 |
| Fitzpatrick Alexander A | officer: Chief Legal Officer | 2026-06-12 | S-Sale | 10 | 2026-06-12 |
| Casale Donn | 2026-06-01 | 0 | 2026-06-01 | ||
| Scott Kathleen D. | officer: Chief Financial Officer | 2026-01-02 | A-Award | 11.49 | 2026-01-05 |
| Karas Eric | officer: Chief Commercial Officer | 2026-01-02 | A-Award | 11.49 | 2026-01-05 |
| Fitzpatrick Alexander A | officer: Chief Legal Officer | 2026-01-02 | A-Award | 11.49 | 2026-01-05 |
| Dorsey Brian | officer: Chief Operating Officer | 2026-01-02 | A-Award | 11.49 | 2026-01-05 |
| Chakma Justin | officer: Chief Business Officer | 2026-01-02 | A-Award | 11.49 | 2026-01-05 |
| Tanimoto Sarina | 10 percent owner, officer: CHIEF MEDICAL OFFICER | 2026-01-02 | A-Award | 11.49 | 2026-01-05 |
| Tanimoto Sarina | 10 percent owner, officer: CHIEF MEDICAL OFFICER | 2026-01-02 | A-Award | 11.49 | 2026-01-05 |
| Lowenthal Richard E | director, 10 percent owner, officer: PRESIDENT AND CEO | 2026-01-02 | A-Award | 11.49 | 2026-01-05 |
| Lowenthal Richard E | director, 10 percent owner, officer: PRESIDENT AND CEO | 2026-01-02 | A-Award | 11.49 | 2026-01-05 |
| Dorsey Brian | officer: Chief Operating Officer | 2025-11-13 | M-Exempt | 0.64 | 2025-11-14 |
| Dorsey Brian | officer: Chief Operating Officer | 2025-11-13 | S-Sale | 8.7067 | 2025-11-14 |
| Dorsey Brian | officer: Chief Operating Officer | 2025-11-13 | M-Exempt | 0.64 | 2025-11-14 |
| Chakma Justin | officer: Chief Business Officer | 2025-11-12 | M-Exempt | 0.84 | 2025-11-14 |
| Chakma Justin | officer: Chief Business Officer | 2025-11-12 | S-Sale | 8.9119 | 2025-11-14 |
| Chakma Justin | officer: Chief Business Officer | 2025-11-12 | M-Exempt | 0.84 | 2025-11-14 |
| Chakma Justin | officer: Chief Business Officer | 2025-11-12 | S-Sale | 8.8634 | 2025-11-14 |
| Shah Pratik | director | 2025-11-12 | G-Gift | 0 | 2025-11-14 |
| Shah Pratik | director | 2025-11-12 | G-Gift | 0 | 2025-11-14 |
| Lowenthal Richard E | director, 10 percent owner, officer: PRESIDENT AND CEO | 2025-08-21 | S-Sale | 14.4869 | 2025-08-22 |
| Scott Kathleen D. | officer: Chief Financial Officer | 2025-08-21 | M-Exempt | 1.5 | 2025-08-22 |
| Scott Kathleen D. | officer: Chief Financial Officer | 2025-08-21 | M-Exempt | 1.5 | 2025-08-22 |
| Scott Kathleen D. | officer: Chief Financial Officer | 2025-08-21 | S-Sale | 15 | 2025-08-22 |
| Tanimoto Sarina | 10 percent owner, officer: CHIEF MEDICAL OFFICER | 2025-08-19 | S-Sale | 14.0254 | 2025-08-21 |
| Tanimoto Sarina | 10 percent owner, officer: CHIEF MEDICAL OFFICER | 2025-08-20 | S-Sale | 14.0914 | 2025-08-21 |
| Karas Eric | officer: Chief Commercial Officer | 2025-07-01 | M-Exempt | 1.5 | 2025-07-03 |
| Karas Eric | officer: Chief Commercial Officer | 2025-07-01 | M-Exempt | 1.5 | 2025-07-03 |
| Karas Eric | officer: Chief Commercial Officer | 2025-07-01 | S-Sale | 16.9907 | 2025-07-03 |
| Flynn James E | 10 percent owner | 2025-06-27 | S-Sale | 18.46 | 2025-07-01 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-06-25 | A-Award | 17.26 | 2025-06-27 |
| Dadoo Rajeev | director | 2025-06-25 | A-Award | 17.26 | 2025-06-27 |
| Shah Pratik | director | 2025-06-25 | A-Award | 17.26 | 2025-06-27 |
| Kelly Michael | director | 2025-06-25 | A-Award | 17.26 | 2025-06-27 |
| Islam Saqib | director | 2025-06-25 | A-Award | 17.26 | 2025-06-27 |
| Thompson Peter A. | director | 2025-06-25 | A-Award | 17.26 | 2025-06-27 |
| SAUNDERS BRENT L | director | 2025-06-25 | A-Award | 17.26 | 2025-06-27 |
| SCHNEIDER PHILLIP M | director | 2025-06-25 | A-Award | 17.26 | 2025-06-27 |
| Shawver Laura | director | 2025-06-25 | A-Award | 17.26 | 2025-06-27 |
| Karas Eric | officer: Chief Commercial Officer | 2025-06-18 | M-Exempt | 1.5 | 2025-06-20 |
| Karas Eric | officer: Chief Commercial Officer | 2025-06-18 | M-Exempt | 1.5 | 2025-06-20 |
| Karas Eric | officer: Chief Commercial Officer | 2025-06-18 | S-Sale | 16 | 2025-06-20 |
| Fitzpatrick Alexander A | officer: Chief Legal Officer | 2025-05-20 | M-Exempt | 5.58 | 2025-05-22 |
| Fitzpatrick Alexander A | officer: Chief Legal Officer | 2025-05-20 | M-Exempt | 5.58 | 2025-05-22 |
| Fitzpatrick Alexander A | officer: Chief Legal Officer | 2025-05-20 | S-Sale | 14.0966 | 2025-05-22 |
| SAUNDERS BRENT L | director | 2025-05-20 | M-Exempt | 1.01 | 2025-05-22 |
| SAUNDERS BRENT L | director | 2025-05-20 | M-Exempt | 1.01 | 2025-05-22 |
| SAUNDERS BRENT L | director | 2025-05-20 | S-Sale | 14.2502 | 2025-05-22 |
| Scott Kathleen D. | officer: Chief Financial Officer | 2025-05-20 | M-Exempt | 1.5 | 2025-05-22 |
| Scott Kathleen D. | officer: Chief Financial Officer | 2025-05-20 | M-Exempt | 1.5 | 2025-05-22 |
| Scott Kathleen D. | officer: Chief Financial Officer | 2025-05-20 | S-Sale | 14.1033 | 2025-05-22 |
| Shawver Laura | director | 2025-04-07 | M-Exempt | 4.85 | 2025-04-08 |
| Shawver Laura | director | 2025-04-07 | M-Exempt | 4.85 | 2025-04-08 |
| Shawver Laura | director | 2025-04-07 | S-Sale | 12.301 | 2025-04-08 |
| Shawver Laura | director | 2025-04-07 | M-Exempt | 4.85 | 2025-04-08 |
| Shawver Laura | director | 2025-04-07 | M-Exempt | 4.85 | 2025-04-08 |
| Karas Eric | officer: Chief Commercial Officer | 2025-03-20 | M-Exempt | 1.5 | 2025-03-21 |
| Karas Eric | officer: Chief Commercial Officer | 2025-03-20 | M-Exempt | 1.5 | 2025-03-21 |
| Karas Eric | officer: Chief Commercial Officer | 2025-03-20 | S-Sale | 14 | 2025-03-21 |
| Shawver Laura | director | 2025-03-06 | M-Exempt | 4.85 | 2025-03-07 |
| Shawver Laura | director | 2025-03-05 | M-Exempt | 4.85 | 2025-03-07 |
| Shawver Laura | director | 2025-03-06 | S-Sale | 11.2106 | 2025-03-07 |
| Shawver Laura | director | 2025-03-05 | S-Sale | 11 | 2025-03-07 |
| Shawver Laura | director | 2025-03-05 | M-Exempt | 4.85 | 2025-03-07 |
| Shawver Laura | director | 2025-03-06 | M-Exempt | 4.85 | 2025-03-07 |
| Shawver Laura | director | 2025-02-03 | M-Exempt | 4.85 | 2025-02-04 |
| Shawver Laura | director | 2025-02-03 | M-Exempt | 3.15 | 2025-02-04 |
| Shawver Laura | director | 2025-02-03 | S-Sale | 12.3113 | 2025-02-04 |
| Shawver Laura | director | 2025-02-03 | M-Exempt | 4.85 | 2025-02-04 |
| Shawver Laura | director | 2025-02-03 | M-Exempt | 3.15 | 2025-02-04 |
| Shawver Laura | director | 2025-01-06 | M-Exempt | 3.15 | 2025-01-07 |
| Shawver Laura | director | 2025-01-06 | S-Sale | 11.1013 | 2025-01-07 |
| Shawver Laura | director | 2025-01-06 | M-Exempt | 3.15 | 2025-01-07 |
| Fitzpatrick Alexander A | officer: Chief Legal Officer | 2025-01-02 | A-Award | 10.71 | 2025-01-03 |
| Dorsey Brian | officer: Chief Operating Officer | 2025-01-02 | A-Award | 10.71 | 2025-01-03 |
| Tanimoto Sarina | 10 percent owner, officer: CHIEF MEDICAL OFFICER | 2025-01-02 | A-Award | 10.71 | 2025-01-03 |
| Tanimoto Sarina | 10 percent owner, officer: CHIEF MEDICAL OFFICER | 2025-01-02 | A-Award | 10.71 | 2025-01-03 |
| Lowenthal Richard E | director, 10 percent owner, officer: PRESIDENT AND CEO | 2025-01-02 | A-Award | 10.71 | 2025-01-03 |
| Lowenthal Richard E | director, 10 percent owner, officer: PRESIDENT AND CEO | 2025-01-02 | A-Award | 10.71 | 2025-01-03 |
| Chakma Justin | officer: Chief Business Officer | 2025-01-02 | A-Award | 10.71 | 2025-01-03 |
| Scott Kathleen D. | officer: Chief Financial Officer | 2025-01-02 | A-Award | 10.71 | 2025-01-03 |
| Karas Eric | officer: Chief Commercial Officer | 2025-01-02 | A-Award | 10.71 | 2025-01-03 |
| Tanimoto Sarina | 10 percent owner, officer: CHIEF MEDICAL OFFICER | 2024-12-17 | S-Sale | 11.6715 | 2024-12-19 |
| Tanimoto Sarina | 10 percent owner, officer: CHIEF MEDICAL OFFICER | 2024-12-17 | S-Sale | 11.6705 | 2024-12-19 |
| Lowenthal Richard E | director, 10 percent owner, officer: PRESIDENT AND CEO | 2024-12-17 | S-Sale | 11.6715 | 2024-12-19 |
| Lowenthal Richard E | director, 10 percent owner, officer: PRESIDENT AND CEO | 2024-12-17 | S-Sale | 11.6705 | 2024-12-19 |
| Chakma Justin | officer: Chief Business Officer | 2024-12-12 | M-Exempt | 0.84 | 2024-12-13 |